Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Minerva Anestesiol ; 84(12): 1352-1360, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-29856175

RESUMEN

BACKGROUND: General anesthesia may be a risk factor for post-operative cognitive impairment, which could be counteracted by neuroprotective compounds. The aims of this study were to determine cognitive functions impaired by general anesthesia and to test blueberry juice as a neuroprotective agent against neuropsychological dysfunctions induced by general anesthesia. METHODS: Twenty-six patients undergoing elective major surgery were randomized into two groups, receiving either 500 mL/day of blueberry juice within 14 preoperative days (G1) or to a control group (G0). Neuropsychological tests were performed around 20 days before surgery (T0), as well as both three hours (T1) and 24 hours (T2) after surgery. All the scores were statistically analyzed to find significant differences between groups and within the three times. RESULTS: The control (G0) group showed a significant decrease in the performance in the Prose Memory Test (P<0.001), the Attentional Matrices Test (P<0.01), and the Trail Making Test Part B (P<0.01) after general anesthesia. Significant differences were reported in the Prose Memory test, T0 versus T1 (P<0.01), T0 versus T2 (P<0.001); in the Trail Making Test Part B, T0 versus T2 (P<0.01); and the Attentional Matrices test, and T0 versus T2 (P<0.001). The G1 group did not show any decrease in the performance of the three tests. CONCLUSIONS: General anesthesia induces a short-term impairment of verbal memory and selective and divided attention. Blueberry compounds may prevent these neuropsychological deficits through a neuroprotective action in patients undergoing general anesthesia.


Asunto(s)
Anestesia General/efectos adversos , Arándanos Azules (Planta) , Disfunción Cognitiva/etiología , Disfunción Cognitiva/prevención & control , Jugos de Frutas y Vegetales , Fármacos Neuroprotectores/uso terapéutico , Fitoterapia , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/prevención & control , Anciano , Humanos , Proyectos Piloto , Factores de Tiempo
2.
Nutr Clin Pract ; 30(1): 104-10, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25516536

RESUMEN

BACKGROUND: Thiamine plays a critical role in energy metabolism. Critically ill patients may have thiamine deficiency and increased mortality due to potentially irreversible consequences. The aim of this study was to show the impact of thiamine deficiency in a series of patients and the rapid response to thiamine replacement, showing the changes in clinical and metabolic conditions over time. METHODS: We described 3 cases of hospitalized patients who had received parenteral nutrition (PN) without vitamin supplementation. All the patients were admitted to the ICU between 2010 and 2011 with a severe form of lactic acidosis, an unstable circulatory state, and a different neurological disorder (a lethargic state, a severe form of impaired near-coma consciousness, and Wernicke encephalopathy). RESULTS: Intravenous (IV) administration of thiamine was associated with a rapid and marked restoration of acid-base balance, hemodynamic stability and the disappearance of neurological disturbances, and normalization of the clinical and biochemical conditions of all the patients within the following hours. CONCLUSIONS: The 3 cases demonstrated the rapidity of the reversal of severe thiamine deficiency, achieved by appropriate replacement in different hospitalized patients. The regression of clinical and biochemical disorders requires a prompt diagnosis and treatment based on the IV administration of thiamine and magnesium sulfate. In hospitalized patients at risk, thiamine deficiency is prevented by the integration of thiamine supplementation into PN and other forms of nutrition support.


Asunto(s)
Acidosis Láctica/tratamiento farmacológico , Enfermedad Crítica/terapia , Nutrición Parenteral/efectos adversos , Deficiencia de Tiamina/tratamiento farmacológico , Tiamina/administración & dosificación , Tiamina/uso terapéutico , Acidosis Láctica/sangre , Acidosis Láctica/etiología , Administración Intravenosa , Adulto , Anciano , Femenino , Humanos , Enfermedades del Sistema Nervioso/sangre , Enfermedades del Sistema Nervioso/tratamiento farmacológico , Enfermedades del Sistema Nervioso/etiología , Nutrición Parenteral/métodos , Choque/sangre , Choque/tratamiento farmacológico , Choque/etiología , Deficiencia de Tiamina/complicaciones , Deficiencia de Tiamina/etiología , Resultado del Tratamiento
3.
Nutr Neurosci ; 14(3): 119-25, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21756533

RESUMEN

OBJECTIVE: The aim of this work was to highlight the effects and the possible mechanisms of the action of blueberry polyphenols on the central nervous system (CNS). METHODS: An analysis was carried out, in a temporal order, of the most important literature about this topic and the results have been correlated with the beneficial and protective effects, mainly concerning the CNS. DISCUSSION: Over the last 10 years an increasing scientific interest has developed about polyphenols, which are very abundant in blueberries, as they have been seen to produce favourable effects related to neuroprotection and linked to a possible decrease of age-related cognitive and motor decline, as shown by the improvement of such functions in animal models with a supplemented diet. Such effects could not only be explained through a purely antioxidant action but also through more complex mechanisms related to inflammation, genic expression, and regulation of cell survival. CONCLUSIONS: Despite the wealth of data from animal studies, there is a relative lack of data concerning human beings, even if some positive results are beginning to emerge. Therefore, blueberry polyphenols could become useful pharmacological agents for various conditions including neurological diseases, but further studies are still necessary to attain this objective.


Asunto(s)
Antioxidantes/farmacología , Arándanos Azules (Planta)/química , Fármacos Neuroprotectores/farmacología , Extractos Vegetales/farmacología , Polifenoles/farmacología , Envejecimiento/efectos de los fármacos , Animales , Sistema Nervioso Central/efectos de los fármacos , Humanos , Inflamación/tratamiento farmacológico , Modelos Animales , Estrés Oxidativo/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA